The vision of the Snowdome Foundation is to ensure every Australian blood cancer
patient has the best opportunity for a cure, and this starts with a correct diagnosis.
We collaborate with world-leading Australian and international blood cancer researchers
to accelerate new therapies and bring next-generation treatments to patients, faster.
We are the leading not-for-profit organisation focused exclusively on raising funds to
support translational research and clinical trials that will accelerate new treatments
(and cures) to help Australian blood cancer patients live longer, better lives.
Over $53 million has been committed to blood cancer research since 2010.
67 research projects funded enabling over 98 research positions.
Over 6,200 genomic tests completed at the Wilson Centre for Blood Cancer Genomics.
Enabled 1,817 patients to participate in clinical trials supported by Snowdome.
Latest News
Prof. Miles Prince receives Winsome Constance Kindness Award
Snowdome co-founder and director, Prof. Miles Prince AM, received the Winsome Constance Kindness Award for his dedication to blood cancer research.
Read moreOptimising Immunotherapy for Aggressive Lymphoma
Earlier this year, the Snowdome Foundation supported a fellowship to optimise immunotherapy for aggressive lymphoma.
Read moreProgress Report: 2022 Snowdome Haematology Fellowship
2022 Snowdome Haematology Fellow, Dr Josh Tobin provides an update on his research into biomarker-directed immunotherapy in advanced stage follicular lymphoma.
Read more